Cocrystal Pharma (COCP) Stock Analysis: AI Score & Alternative Data
Alt-data signals are cooling for Cocrystal Pharma
Is Cocrystal Pharma a buy right now? The alternative data says hold. This COCP stock analysis is built on the 25+ alternative data signals AltIndex tracks on Cocrystal Pharma every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 50/100: a Hold. The stock trades at $1.07 with a $21M market cap.
The soft spots over the past 90 days: web traffic down 17.4% to 3K monthly visits. The rest of the signal set is holding steady, which keeps COCP at a hold rather than a sell.
COCP’s broader alt-data profile also covers headcount (15 employees, according to LinkedIn), X followers (1K), and sentiment (100/100). Every signal links to its own page with full history, the COCP technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on COCP is just below.
Cocrystal Pharma AI Stock Analysis
Cocrystal Pharma is a biotechnology company focused on discovering and developing novel antiviral therapeutics for the treatment of serious and/or chronic viral diseases. The company employs proprietary structure-based technologies to create first-in-class and best-in-class antivirals.
Analysis generated October 1, 2026.
Recent Cocrystal Pharma Stock Alerts
|
Cocrystal Pharma | September 30 Price is up by 6.3% in the last 24h. |
|
Cocrystal Pharma | September 29 Price is down by -7.4% in the last 24h. |
|
Cocrystal Pharma | September 9 Price is up by 6.8% in the last 24h. |
|
Cocrystal Pharma | September 8 Price is up by 6.2% in the last 24h. |
Cocrystal Pharma Alternative Data
| Alternative Data | Value | 3m Change | Trend |
|---|---|---|---|
| Webpage Traffic | 3K | 17.4% | |
| Job Posts | 0 | N/A | |
| LinkedIn Employees | 15 | 0% | |
| Employee Recommend | 100 | 0% | |
| Business Outlook | 0 | N/A | |
| Sentiment | 100 | 0% | |
| Reddit Mentions | 0 | N/A | |
| X Mentions | 1 | 0% | |
| Stocktwits Mentions | 4 | 100.0% | |
| News Mentions | 0 | N/A | |
| Stocktwits Subscribers | 16K | 0% | |
| X Followers | 1K | 0.5% | |
| Facebook Followers | 541 | 0% | |
| Facebook Engagement | 0 | N/A |
About Cocrystal Pharma (COCP)
Cocrystal Pharma, Inc., a biotechnology company, is focused on the discovery and development of antiviral therapeutic treatments for serious and / or chronic viral diseases. The company is headquartered in Bothell, Washington.
| Price | $1.07 |
| Target Price | $387.74 |
| Volume | 63,420,177 |
| Market Cap | $21M |
| Year Range | $1 – $2 |
| Dividend Yield | 0% |
| PE Ratio | — |
| Analyst Rating | 38% buy |
| Industry | Biotechnology |
Latest Cocrystal Pharma News
View more →
Cocrystal Pharma: The Strategic Reset Investors May Be MissingAugust 31 - Yahoo Entertainment |
|
Cocrystal Pharma Announces $5 Million Private Placement with OPKO HealthAugust 3 - GlobeNewswire |
|
Cocrystal Pharma Provides Business Update and Reports First Quarter 2026 Financial ResultsMay 15 - GlobeNewswire |
|
Gynecology Collaboration and Licensing Agreements Benchmark Report 2026: Structured Analysis of 157 Deals, Delivering an Evidence-based View of How Partnerships are Designed, Negotiated, and ExecutedMay 19 - GlobeNewswire |
See Cocrystal Pharma’s complete price and AI Score history
Sign up to unlock 1-year and all-time charts for COCP, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREECocrystal Pharma Earnings & Financial Performance
View all earnings →Cocrystal Pharma Insider Trading Activity
View all →| FROST PHILLIP MD ET AL filed to sell 1,993,551 shares at $0.0. Aug 5 '26 |
| FROST PHILLIP MD ET AL filed to sell 1,983,551 shares at $0.0. Aug 3 '26 |
| FROST PHILLIP MD ET AL filed to sell 1,908,551 shares at $0.0. Feb 24 '26 |
| FROST PHILLIP MD ET AL filed to sell 1,888,551 shares at $0.0. Feb 6 '26 |
| FROST PHILLIP MD ET AL filed to sell 1,838,551 shares at $0.0. Dec 31 '25 |
Cocrystal Pharma Congress Trading
View all →| Politician | Filing Date | Type | Size |
|---|---|---|---|
| No congress trades on file. | |||
Stocks Similar to Cocrystal Pharma
See all →| Company | Price | Market Cap | AI Score | |
|---|---|---|---|---|
 |
Vyne TherapeuticsVYNE |
$28.56 12.2% | $19M | 47 |
 |
SeaStar Medical HoldingICU |
$3.61 3.4% | $19M | 63 |
 |
Jasper TherapeuticsJSPR |
$0.57 1.8% | $19M | 54 |
 |
Akari TherapeuticsAKTX |
$8.77 7.9% | $19M | 48 |
 |
Dyadic InternationalDYAI |
$0.44 0.1% | $18M | 50 |
Explore Cocrystal Pharma Data
Frequently Asked Questions: Cocrystal Pharma (COCP)
Cocrystal Pharma has an AltIndex AI Score of 50/100 (Hold). The score reflects mixed alternative data signals. All investments carry risk.
50/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.
Currently, the price of one share of Cocrystal Pharma (COCP) stock is $1.07 with a market cap of $21M.
As of today, Cocrystal Pharma’s PE (Price to Earnings) ratio is —.
View the latest Cocrystal Pharma insider transactions to see recent buying and selling activity by company executives and directors.
Check the Cocrystal Pharma congress trading page for the latest disclosed trades by U.S. senators and representatives.
AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.
The COCP stock price chart above shows Cocrystal Pharma’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full Cocrystal Pharma technical analysis for RSI, moving averages, and more.
See the stocks similar to Cocrystal Pharma section on this page for companies in the same industry ranked by market cap and AI Score.
